Search

Search bills, members, committees and pages...

S 444

North Carolina SenateIntroduced

Summary

S 444, the Controlled Substances Act - Updates, was introduced in the Senate on Mar 24, 2025 by Sen. Bobby Hanig (R) with 2 co-sponsors. It was referred to Rules and Operations of the Senate, and last saw action on Mar 25, 2025: Ref To Com On Rules and Operations of the Senate.


Record

Text

S 444 has 2 co-sponsors.

s444/amended.txt
GENERAL ASSEMBLY OF NORTH CAROLINA
SESSION 2025
S 1
SENATE BILL 444
Short Title: Controlled Substances Act - Updates. (Public)
Sponsors: Senator Hanig (Primary Sponsor).
Referred to: Rules and Operations of the Senate
March 25, 2025
A BILL TO BE ENTITLED
AN ACT TO UPDATE THE CONTROLLED SUBSTANCES ACT.
The General Assembly of North Carolina enacts:
SECTION 1.(a) G.S. 90-89(1) reads as rewritten:
"(1) Opiates. – Any of the following opiates or opioids, including the isomers,
esters, ethers, salts and salts of isomers, esters, and ethers, unless specifically
excepted, or listed in another schedule, whenever the existence of such
isomers, esters, ethers, and salts is possible within the specific chemical
designation:
sss. AP-237.
ttt. 2-methyl AP-237.
uuu. (ortho, meta, or para)-methyl AP-237.
vvv. AP-238.
www. (ortho, meta, or para)-hydroxy 2-methyl AP-237.
xxx. 2-Naphthyl U-47700.
yyy. 1-Naphthyl U-47700.
zzz. 4-(Trifluoromethyl) U-47700.
aaaa. Methoxy U-47700.
bbbb. Furanyl UF-17.
cccc. Cyclopropyl U-47700.
dddd. Phenyl U-47700.
eeee. Ethyl U-47700.
ffff. (2,3- or 3,4)-difluoro-N,N-didesmethyl U-47700.
gggg. (2,3- or 3,4)-difluoro U-49900.
hhhh. (2,3- or 3,4)-difluoro-N-desmethyl U-47700.
iiii. 4-fluoro U-47931E.
jjjj. (2,3- or 3,4)-difluoro U-51754.
kkkk. (2,3- or 3,4)-difluoro Isopropyl U-47700.
llll. (2,3- or 3,4)-difluoro Propyl U-47700.
mmmm. (2,3- or 3,4)-difluoro U-50488.
nnnn. (2,3- or 3,4)-difluoro U-48800.
oooo. (2,3- or 3,4 or 2,4)-difluoro U-47700.
pppp. UF-17.
qqqq. U-47109.
rrrr. U-48520.
*S444-v-1*
General Assembly Of North Carolina Session 2025
ssss. N,N-didesmethyl U-47700.
tttt. U-62066.
uuuu. Propyl U-47700.
vvvv. (2,3- or 3,4)-Ethylenedioxy U-51754.
wwww. 4-phenyl U-51754.
xxxx. N-desmethyl U-47700.
yyyy. (2,3- or 3,4)-Ethylenedioxy U-47700.
zzzz. N-methyl U-47931E.
aaaaa. (2,3- or 3,4)-Methylenedioxy U-47700.
bbbbb. U-69593.
ccccc. U-50488.
ddddd. U-48753E.
eeeee. U-47931E."
SECTION 1.(b) G.S. 90-89(1a) reads as rewritten:
"(1a) Fentanyl derivatives. – Unless specifically excepted, listed in another
schedule, or contained within a pharmaceutical product approved by the
United States Food and Drug Administration, any compound structurally
derived from N-[1-(2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide
(Fentanyl) by any substitution on or replacement of the phenethyl group, any
substitution on the piperidine ring, any substitution on or replacement of the
propanamide group, any substitution on the anilido phenyl group, or any
combination of the above unless specifically excepted or listed in another
schedule to include their salts, isomers, and salts of isomers. Fentanyl
derivatives include, but are not limited to, the following:
f.
N-(2-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propana
mide (also known as 2-fluorofentanyl).(also known as
ortho-fluorofentanyl).
g.
N-(3-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propana
mide (also known as 3-fluorofentanyl).(also known as
meta-fluorofentanyl).
i.
N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4-piperidinyl]
-propanamide (also known as 4-fluoroisobutyryl fentanyl,
4-FIBF).(also known as 4-fluoroisobutyryl fentanyl).
j. N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-butanamide
(also known as 4-fluorobutyryl fentanyl, 4-FBF).(also known as
para-fluorobutyryl fentanyl)."
SECTION 1.(c) G.S. 90-89 is amended by adding a new subdivision to read:
"(1b) Nitazene derivatives. – The N-substituted benzimidazole structural class,
including any of the following derivatives, their salts, isomers, or salts of
isomers unless specifically utilized as part of the manufacturing process by a
commercial industry of a substance or material not intended for human
ingestion or consumption, as a prescription administered under medical
supervision, or for research at a recognized institution, whenever the existence
of these salts, isomers, or salts of isomers is possible within the specific
chemical designation or unless specifically excepted or listed in this or another
schedule, structurally derived from benzimidazole by substitution at the
Page 2 Senate Bill 444-First Edition
General Assembly Of North Carolina Session 2025
1-position nitrogen with an ethylamine group, and by substitution at the
2-position carbon with a benzyl group, whether or not the compound is further
modified in any of the following ways:
a. By monoalkyl or dialkyl substitution on the 1'-nitrogen of the
1-position ethylamine group, or by inclusion of the nitrogen in a cyclic
structure.
b. By substitution on the 2'-methylene carbon of the benzyl group by
alkyl or carboxamide groups.
c. By replacement of the 2'-methylene carbon group with an ethylbenzyl,
thiophenol, or methoxybenzene group, which may be further
substituted with alkyl, hydroxyl, alkoxy, acetoxy, halide, or sulfide
groups.
d. By substitution at the 2'-position, 3'-position, or 4'-position of the
benzyl group, or both, with alkyl, hydroxyl, alkoxy, acetoxy, halide,
or sulfide groups.
e. By replacement of a phenyl hydrogen atom at either the 5-position or
6-position of the benzimidazole core with a nitro, or primary amine
group."
SECTION 1.(d) G.S. 90-89(3)mm. reads as rewritten:
"mm. 5-methoxy-N-methyl-N-propyltryptamine
(5-MeO-MiPT).5-methoxy-N-methyl-N-isopropyltryptamine
(5-MeO-MiPT)."
SECTION 1.(e) G.S. 90-89(4) is amended by adding a new sub-subdivision to read:
"j. Bromazolam."
SECTION 1.(f) G.S. 90-89(5)j. reads as rewritten:
"j. Substituted cathinones. A compound, other than bupropion, that is
structurally derived from 2-amino-1-phenyl-1-propanone by
modification in any of the following ways: (i) by substitution in the
phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl,
or halide substituents, whether or not further substituted in the phenyl
ring by one or more other univalent substituents; (ii) by substitution at
the 3-position to any extent; or (iii) by substitution at the nitrogen atom
with alkyl, dialkyl, benzyl, cycloalkyl, or methoxybenzyl groups or by
inclusion of the nitrogen atom in a cyclic structure. For the purpose of
this paragraph, the term "isomer" includes the optical, positional, or
geometric isomer."
SECTION 1.(g) G.S. 90-89(7) reads as rewritten:
"(7) Synthetic cannabinoids. – Any quantity of any synthetic chemical compound
that (i) is a cannabinoid receptor agonist and mimics the pharmacological
effect of naturally occurring substances or (ii) has a stimulant, depressant, or
hallucinogenic effect on the central nervous system that is not listed as a
controlled substance in Schedules I through V, and is not an FDA-approved
drug. Synthetic cannabinoids include, but are not limited to, the substances
listed in sub-subdivisions a. through p. v. of this subdivision and any substance
that contains any quantity of their salts, isomers (whether optical, positional,
or geometric), homologues, and salts of isomers and homologues, unless
specifically excepted, whenever the existence of these salts, isomers,
homologues, and salts of isomers and homologues is possible within the
specific chemical designation. The following substances are examples of
synthetic cannabinoids and are not intended to be inclusive of the substances
included in this Schedule:
Senate Bill 444-First Edition Page 3
General Assembly Of North Carolina Session 2025
l. Indole carboxamides. Any compound structurally derived from
1H-indole-3-carboxamide or 1H-indole-2-carboxamide substituted in
one or both of the following ways:
1. At the nitrogen atom of the indole ring by an alkyl, haloalkyl,
cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl,
1-(N-methyl-2-pyrrolidinyl)methyl,
1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl,
benzyl, or halo benzyl group; andor
2. At the nitrogen of the carboxamide by a phenyl, benzyl,
naphthyl, adamantyl, cyclopropyl, or propionaldehyde
group;group, or methyl 3,3-dimethyl-butanoate group;
whether or not the compound is further modified to any extent
in the following ways: (i) substitution to the indole ring to any
extent, (ii) substitution to the phenyl, benzyl, naphthyl,
adamantyl, cyclopropyl, or propionaldehyde group to any
extent, (iii) a nitrogen heterocyclic analog of the indole ring, or
(iv) a nitrogen heterocyclic analog of the phenyl, benzyl,
naphthyl, adamantyl, or cyclopropyl ring. Substances in this
class include, but are not limited to: SDB-001 and
STS-135.STS-135 and MDMB-ICA.
n. Indazole carboxaldehydes. Any compound structurally derived from
1H-indazole-3-carboxaldehyde or 1H-indazole-2-carboxaldehyde
substituted in both of the following ways:
2. At the carbon of the carboxaldehyde by a phenyl, benzyl,
naphthyl, adamantyl, cyclopropyl, or propionaldehyde group;
whether or not the compound is further modified to any extent
in the following ways: (i) substitution to the indazole ring to
any extent, (ii) substitution to the phenyl, benzyl, naphthyl,
adamantyl, cyclopropyl, or propionaldehyde group to any
extent, (iii) a nitrogen heterocyclic analog of the indazole ring,
or (iv) a nitrogen heterocyclic analog of the phenyl, benzyl,
naphthyl, adamantyl, or cyclopropyl ring.
o. Indazole carboxamides. Any compound structurally derived from
1H-indazole-3-carboxamide or 1H-indazole-2-carboxamide
substituted in one or both of the following ways:
1. At the nitrogen atom of the indazole ring by an alkyl, haloalkyl,
cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl,
1-(N-methyl-2-pyrrolidinyl)methyl,
1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl,
benzyl, or halo benzyl group; andor
2. At the nitrogen of the carboxamide by a phenyl, benzyl,
naphthyl, adamantyl, cyclopropyl, or propionaldehyde
group;group, or methyl 3,3-dimethyl-butanoate group;
whether or not the compound is further modified to any extent
in the following ways: (i) substitution to the indazole ring to
any extent, (ii) substitution to the phenyl, benzyl, naphthyl,
Page 4 Senate Bill 444-First Edition
General Assembly Of North Carolina Session 2025
adamantyl, cyclopropyl, or propionaldehyde group to any
extent, (iii) a nitrogen heterocyclic analog of the indazole ring,
or (iv) a nitrogen heterocyclic analog of the phenyl, benzyl,
naphthyl, adamantyl, or cyclopropyl ring. Substances in this
class include, but are not limited to: AKB-48, fluoro-AKB-48,
APINCACA, AB-PINACA, AB-FUBINACA,
ADB-FUBINACA, and ADB-PINACA.ADB-PINACA,
ADB-INACA, MDMB-INACA, MDMB-5Me-INACA, and
MDMB-5Br-INACA.
s. Oxindoles. Any compound structurally derived from
3-hydrazonoindolin-2-one substituted in one or both of the following
ways:
1. At the nitrogen atom of the oxoindole ring by an alkyl,
haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl; or
2. At the nitrogen of the hydrazide by a phenyl, benzyl, naphthyl,
adamantyl, cyclopropyl, or propionaldehyde group; whether or
not the compound is further modified to any extent in the
following ways: (i) substitution to the oxoindole ring to any
extent or (ii) substitution to the phenyl, benzyl, naphthyl,
adamantyl, cyclopropyl, or propionaldehyde group to any
extent. Substances in this class include, but are not limited to:
BZO-POXIZID, BZO-HEXOXIZIDE, 5F-BZO-POXIZIDE.
t. Indole acetamides. Any compound structurally derived from
1H-indole-3-acetamide or 1H-indole-2-acetamide substituted in one or
both of the following ways:
1. At the nitrogen atom of the indole ring by an alkyl, haloalkyl,
cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl,
1-(N-methyl-2-pyrrolidinyl)methyl,
1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl,
benzyl, or halo benzyl group; or
2. At the nitrogen of the acetamide by a phenyl, benzyl, naphthyl,
adamantyl, cyclopropyl, or propionaldehyde group; whether or
not the compound is further modified to any extent in the
following ways: (i) substitution to the indole ring to any extent,
(ii) substitution to the phenyl, benzyl, naphthyl, adamantyl,
cyclopropyl, or propionaldehyde group to any extent, (iii) a
nitrogen heterocyclic analog of the indole ring, or (iv) a
nitrogen heterocyclic analog of the phenyl, benzyl, naphthyl,
adamantyl, or cyclopropyl ring. Substances in this class
include, but are not limited to: AFUBIATA, CH-PIATA,
AB-CHMIATA, ADB-FUBIATA.
u. Indazole acetaldehydes. Any compound structurally derived from
1H-indazol-3-ylacetaldehyde or 1H-indazol-2-ylacetaldehyde
substituted in one or both of the following ways:
1. At the nitrogen atom of the indazole ring by an alkyl, haloalkyl,
cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl,
1-(N-methyl-2-pyrrolidinyl)methyl,
Senate Bill 444-First Edition Page 5
General Assembly Of North Carolina Session 2025
1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl,
benzyl, or halo benzyl group; or
2. At the nitrogen of the carboxamide by a phenyl, benzyl,
naphthyl, adamantyl, cyclopropyl, or propionaldehyde group;
whether or not the compound is further modified to any extent
in the following ways: (i) substitution to the indazole ring to
any extent, (ii) substitution to the phenyl, benzyl, naphthyl,
adamantyl, cyclopropyl, or propionaldehyde group to any
extent, (iii) a nitrogen heterocyclic analog of the indazole ring,
or (iv) a nitrogen heterocyclic analog of the phenyl, benzyl,
naphthyl, adamantyl, or cyclopropyl ring. Substances in this
class include, but are not limited to: ADB-BUTINAATA,
ADB-FUBINAATA.
v. Pyrazoles. Any compound structurally derived from 1H-pyrazole
substituted in all of the following ways:
1. At the 1 position of the pyrazole ring by an alkyl, haloalkyl, or
alkenyl group.
2. At the 3 position of the pyrazole ring by a halo benzyl or
propionaldehyde group.
3. At the 5 position of the pyrazole ring by a halo benzyl or
propionaldehyde group; whether or not the compound is
further modified by a substitution to the propionaldehyde
group to any extent. Substances in this class include, but are
not limited to: 3,5-ADB-4en-PFUPPYCA,
5-fluoro-3,5-AB-PFUPPYCA."
SECTION 1.(h) G.S. 90-90(2)h1. reads as rewritten:
"h1. Fentanyl immediate precursor chemical,
4-anilino-N-phenethyl-4-piperidine
(ANPP).4-anilino-N-phenethylpiperdine (ANPP)."
SECTION 1.(i) G.S. 90-91(k)11. reads as rewritten:
"11. Dehydrochlormethyltestosterone,Dehydrochloromethyltestosterone,"
SECTION 1.(j) G.S. 90-91(k)16. reads as rewritten:
"16. Mesterolene,Mesterolone,"
SECTION 2. This act is effective when it becomes law.
Page 6 Senate Bill 444-First Edition

Controlled Substances Act - Updates

Sponsors

Sen. Bobby Hanig (R) sponsors S 444, and 2 members have co-sponsored it.

Committees

S 444 went before 1 committee: Rules and Operations of the Senate.

Rules and Operations of the Senate
Rules and Operations of the Senate
Referred to · Mar 25, 2025

History

S 444 has taken 3 actions since Mar 24, 2025, the latest on Mar 25, 2025.

ChamberAction
Mar 25, 2025
Senate
Passed 1st Reading
Mar 25, 2025
Senate
Ref To Com On Rules and Operations of the Senate
Mar 24, 2025
Senate
Filed

Votes

S 444 has not gone to a roll call.


Source: ncleg.gov · legiscan.com